Workflow
CHALKIS(000972)
icon
Search documents
中基健康(000972) - 2020 Q2 - 季度财报
2020-08-30 16:00
Financial Performance - The company's operating revenue for the first half of 2020 was ¥2,821,694.08, a decrease of 98.59% compared to ¥200,278,061.07 in the same period last year[18]. - The net profit attributable to shareholders was a loss of ¥44,744,193.51, compared to a profit of ¥28,211,162.65 in the previous year[18]. - The net cash flow from operating activities was a negative ¥6,808,897.15, down from a positive ¥33,811,759.18 in the same period last year[18]. - Total revenue for the reporting period was CNY 2,821,694.08, a decrease of 98.59% compared to CNY 200,278,061.07 in the same period last year, primarily due to factory shutdowns[35]. - The company's net profit attributable to shareholders was CNY -44,744,193.51, with net assets amounting to CNY 397,192,414.00[34]. - The net loss for the first half of 2020 was CNY 44,769,204.53, compared to a net profit of CNY 28,125,891.52 in the first half of 2019, marking a shift of approximately 258.5%[131]. - The total comprehensive loss for the first half of 2020 was CNY 44,769,204.53, compared to a comprehensive income of CNY 28,125,891.52 in the first half of 2019[131]. - The total comprehensive income for the period was -44,744,193.51 CNY, a significant decrease compared to the previous period[148]. Assets and Liabilities - The total assets at the end of the reporting period were ¥658,171,568.81, a decrease of 11.09% from ¥740,282,440.65 at the end of the previous year[18]. - The company's current assets totaled CNY 277,493,814.29, down from CNY 336,301,718.81 at the end of 2019, indicating a decrease of about 17.4%[121]. - The total liabilities decreased from CNY 292,346,652.15 to CNY 255,004,984.84, a decline of approximately 12.8%[122]. - The company's equity attributable to shareholders decreased from CNY 441,936,607.51 to CNY 397,192,414.00, a reduction of about 10.1%[123]. - The total equity at the end of the reporting period was 696,904,112.88 CNY, reflecting a decrease from the previous period[165]. Operational Changes and Strategies - The company plans to suspend operations at its wholly-owned subsidiary, Hongse Fanqie Factory, to improve asset structure and reduce burdens[26]. - The company is actively working on reforming its subsidiaries to enhance market competitiveness and improve asset utilization efficiency[26]. - The company plans to issue A-shares to raise funds primarily for the construction of a traditional Chinese medicine industrialization base and an emergency medical supplies production base, which will change its main business to medical and pharmaceutical industry development, production, processing, and wholesale[34]. - The company is enhancing its internal vitality and market competitiveness through ongoing reforms and asset optimization[33]. - The company aims to improve its core competitiveness and profitability through strategic adjustments and operational direction changes[57]. - The company plans to leverage capital market financing and restructuring to enhance risk resistance and create new profit growth points[48]. - The company is committed to improving its talent training and recruitment mechanisms to optimize its talent structure and management team[58]. Legal and Compliance Issues - The company faced a significant loss of 113,681,230.79 CNY in net profit attributable to shareholders after deducting non-recurring gains and losses[57]. - The company has faced significant legal disputes with Tianjin Master Printing and Packaging Co., with claims totaling approximately 67.88 million yuan for management fees, inventory losses, and tax credits[66]. - The court ruled that Tianjin Master Printing must pay 9.99 million yuan in management fees and 18.1 million yuan in inventory losses, along with interest[66]. - The company filed an appeal to the Higher People's Court of Xinjiang Uygur Autonomous Region after the initial court rejected its lawsuit[70]. - There were no penalties or rectifications during the reporting period[72]. Shareholder and Equity Information - The total number of ordinary shareholders at the end of the reporting period is 35,480[101]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 124,769,223 shares, accounting for 16.18% of total shares[103]. - The total number of shares before and after the recent changes remains at 771,283,579, with no new shares issued or repurchased[98]. - The company does not have any preferred shares or convertible bonds in the reporting period[107][110]. - There were no changes in the shareholding of directors, supervisors, and senior management during the reporting period[112]. Financial Reporting and Compliance - The financial report for the first half of 2020 was not audited, which may affect the reliability of the financial data presented[118]. - The financial statements comply with the requirements of the enterprise accounting standards, accurately reflecting the company's financial position as of June 30, 2020, and the operating results and cash flows for the first half of 2020[174]. - The company's accounting period is based on the calendar year, running from January 1 to December 31[175]. - The company uses Renminbi as its functional currency for accounting purposes[176]. Research and Development - Research and development expenses increased to CNY 1,542,619.85, reflecting the establishment of a new R&D center and associated personnel costs[35]. - The company has established four new pharmaceutical companies focused on technology research and sales in the health sector[49]. - The company has established four pharmaceutical companies focusing on technology research and sales in the health sector, leveraging the rich medicinal resources in Xinjiang[58]. Corporate Governance - The company emphasizes the importance of strengthening its political core and enhancing party leadership within state-owned enterprises[48]. - The company is focused on enhancing its operational efficiency and modern corporate governance as part of the state-owned enterprise reform pilot[58]. - The board believes that the company can improve its operating conditions and reduce losses through strategic adjustments and operational measures[59]. - The board of directors will continue to monitor and support management in enhancing the company's operational capacity[173].
ST中基:关于参加2020年新疆辖区上市公司投资者网上集体接待日活动的公告
2020-06-18 11:31
证券代码:000972 证券简称:ST中基 公告编号:2020-032号 中基健康产业股份有限公司关于 参加 2020 年新疆辖区上市公司投资者网上集体接待日活动的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性陈述或 者重大遗漏。 为便于广大投资者更深入全面地了解公司情况、发展战略、经营状况、融资计划、 股权激励、可持续发展等投资者所关心的问题,公司定于2020年6月24日下午 15:00-17:30参加由新疆上市公司协会联合深圳市全景网络有限公司组织开展的2020 年新疆辖区上市公司投资者网上集体接待日活动。现将有关事项公告如下: 本次集体接待日活动将在深圳全景网络有限公司提供的网上平台,采取网络远程 的方式举行,投资者可以登录"全景路演天下"网站(http://rs.p5w.net/)或关注 微信公众号:全景财经(微信号:p5w2012),参与公司本次投资者集体接待日活动, 活动时间为 2020 年 6 月 24 日(星期三)15:00-17:30。 出席本次集体接待日的人员有:公司总经理孔繁立先生、董事会秘书邢江先生。 欢迎广大投资者积极参与。 特此公告。 中基健康产业 ...
中基健康(000972) - 2020 Q1 - 季度财报
2020-04-29 16:00
Financial Performance - The company's revenue for Q1 2020 was ¥2,758,230.08, a decrease of 96.99% compared to ¥91,484,302.22 in the same period last year[8] - The net profit attributable to shareholders was -¥13,041,004.34, representing a 45.43% increase in losses compared to -¥8,966,936.17 in the previous year[8] - The basic earnings per share were -¥0.0169, a decline of 45.69% compared to -¥0.0116 in the previous year[8] - Operating revenue plummeted by 96.99% to ¥2,758,230.08 compared to ¥91,484,302.22, attributed to factory shutdowns and no product sales in the first quarter[15] - The net loss for Q1 2020 was CNY 13,053,465.20, compared to a net loss of CNY 9,035,125.01 in Q1 2019, reflecting an increase in losses of approximately 44%[36] - The total comprehensive loss for Q1 2020 was -¥13,053,465.20, compared to -¥9,035,125.01 in Q1 2019, indicating a year-over-year increase in losses of about 44.7%[37] Cash Flow - The net cash flow from operating activities was -¥4,790,684.39, which is a 63.16% improvement from -¥13,002,306.18 in the same period last year[8] - Cash received from sales dropped by 99.98% to ¥4,000.00 from ¥21,623,066.04, indicating no product sales during the quarter[15] - The cash inflow from operating activities was only ¥733,296.72 in Q1 2020, a sharp decline from ¥23,488,846.89 in Q1 2019, representing a decrease of about 96.9%[44] - The company incurred a total cash outflow of ¥48,005,077.36 from financing activities in Q1 2020, compared to ¥16,172,991.27 in Q1 2019, reflecting an increase in cash outflows of about 196.5%[45] - The total cash and cash equivalents at the end of Q1 2020 were ¥26,161,078.33, down from ¥78,956,840.08 at the beginning of the period, indicating a decrease of approximately 66.8%[45] Assets and Liabilities - Total assets at the end of the reporting period were ¥674,451,770.44, down 8.89% from ¥740,282,440.65 at the end of the previous year[8] - The total liabilities decreased from CNY 292,346,652.15 at the end of 2019 to CNY 239,569,447.14 by March 31, 2020, a reduction of about 18%[30] - The total equity attributable to shareholders decreased from CNY 441,936,607.51 at the end of 2019 to CNY 428,895,603.17 by March 31, 2020, a decline of approximately 3%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 36,804[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 16.18% of the shares[10] Operating Costs and Expenses - Operating costs fell by 96.18% to ¥3,347,191.68 from ¥87,733,345.57, reflecting the same shutdown issues[15] - Management expenses increased by 35.12% to ¥11,382,896.18 from ¥8,424,348.49 due to costs associated with the shutdown[15] - Operating expenses increased significantly, with costs rising to ¥1,752,877.32 in Q1 2020 from ¥324,951.77 in Q1 2019, marking a year-over-year increase of approximately 440.5%[39] Other Financial Metrics - The weighted average return on net assets was -3.00%, a decrease of 0.8 percentage points compared to -2.20% in the previous year[8] - The company reported no non-recurring gains or losses during the reporting period[8] - The company received no cash from investment recoveries, a 100% decrease from ¥12,889,980.00 in the previous period[16] - The company reported a financial expense of CNY 1,072,145.61 in Q1 2020, down from CNY 3,938,508.46 in the same period last year, a decrease of approximately 73%[36] Audit and Reporting - The company did not undergo an audit for the first quarter report[49] - The company did not apply new revenue and leasing standards for the current reporting period[49]
中基健康(000972) - 2019 Q4 - 年度财报
2020-04-15 16:00
Financial Performance - The company's operating revenue for 2019 was ¥213,188,826.11, a decrease of 65.98% compared to ¥626,669,589.53 in 2018[16] - The net profit attributable to shareholders in 2019 was ¥4,975,779.02, a significant recovery from a loss of ¥423,854,369.08 in 2018[16] - The net cash flow from operating activities decreased by 65.74% to ¥142,656,995.36 in 2019 from ¥416,334,994.00 in 2018[16] - The total assets at the end of 2019 were ¥740,282,440.65, down 39.65% from ¥1,226,692,417.36 at the end of 2018[16] - The net assets attributable to shareholders increased slightly by 0.79% to ¥441,936,607.51 at the end of 2019 from ¥438,488,610.56 at the end of 2018[16] - The basic earnings per share for 2019 was ¥0.01, recovering from a loss of ¥0.55 in 2018[16] - The weighted average return on net assets improved to 1.13% in 2019 from -64.39% in 2018, an increase of 65.52 percentage points[16] Dividend Policy - The company plans not to distribute cash dividends or issue bonus shares for the year[6] Business Operations - The company has not reported any changes in its main business since its listing[16] - The company has engaged Zhongxing Caiguanghua Accounting Firm for auditing, which issued an unqualified opinion with a paragraph on going concern uncertainty[5] - The company is undergoing a strategic transformation by shutting down certain factories to improve asset structure and reduce burdens[27] - The company is actively pursuing state-owned enterprise reforms to enhance market competitiveness and asset utilization efficiency[28] - The company has established a post-doctoral research workstation to foster talent and enhance technological innovation capabilities[30] - The company is focusing on optimizing resource allocation and improving asset quality to support sustainable development and profitability[29] Revenue Breakdown - The manufacturing sector contributed ¥197,338,730.57, accounting for 92.57% of total revenue, reflecting a 67.83% decline from the previous year[37] - The sales of bulk tomato sauce were ¥192,504,754.63, representing 90.30% of total revenue, down 62.96% year-on-year[38] Asset Management - The company disposed of non-current assets, generating a profit of ¥128,157,791.31 in 2019, compared to ¥120,782,592.49 in 2018[22] - The company is undergoing asset disposals to improve asset quality and enhance sustainable profitability[44] - The company has initiated the transfer of 100% equity in its subsidiary Zhongchen Canning, with an estimated value of ¥42,966,548.09[45] Legal Matters - The company has ongoing litigation against Master Company regarding a lease contract dispute, with claims for management fees and compensation totaling approximately 67.88 million CNY[90][95] - The court ruled that Master Company must pay 9.9947 million CNY in management fees and 18.1 million CNY for inventory losses[95] - The subsidiary Hongse Fanqie is involved in a lawsuit with Tianjin Coal Trading Company over a transportation and storage contract dispute[97] - Red Tomato has filed a lawsuit against Tianjin Coal Trading Company, claiming economic losses totaling RMB 20,981,923.85 due to various breaches of contract, including delayed shipments and misdelivery[100] Corporate Governance - The company is committed to improving its corporate governance and exploring long-term incentive mechanisms for employees[68] - The company has established a comprehensive corporate governance structure that complies with regulatory requirements[192] - The company operates independently from its controlling shareholder in business, personnel, assets, organization, and finance[193] Shareholder Information - The company reported a total share count of 771,283,579, with 100% being unrestricted shares[149] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 16.18% of shares, totaling 124,769,223[152] Environmental Compliance - The company has established a wastewater treatment facility with a processing capacity of 450 m³/h, utilizing a secondary biochemical process[144] - The company has complied with environmental regulations and has obtained the necessary environmental impact assessments and discharge permits[144] Employee Information - The total remuneration for directors, supervisors, and senior management in 2019 amounted to 1.5149 million yuan (including tax) for 9 individuals[183] - The company employed a total of 67 staff members, with 27 in the parent company and 40 in major subsidiaries[186] Future Outlook - The company has set a revenue guidance of 1.5 billion RMB for the next fiscal year, projecting a growth rate of 25%[177] - New product launches are expected to contribute an additional 300 million RMB in revenue in the upcoming year[177] - The company is investing 100 million RMB in R&D for new technologies aimed at enhancing product efficiency[177]
中基健康(000972) - 2019 Q3 - 季度财报
2019-10-31 16:00
Financial Performance - Operating revenue fell by 99.21% to ¥799,854.20, with a year-to-date revenue decline of 54.07% to ¥201,077,915.27[9] - Net profit attributable to shareholders was a loss of ¥5,350,650.69, with a year-to-date net profit of ¥22,860,511.96[9] - Basic and diluted earnings per share were both -¥0.007, compared to ¥0.0296 in the same period last year[9] - The net profit for the current period is CNY -5,426,876.19, an improvement compared to CNY -32,642,270.56 in the previous period[40] - The total comprehensive income for the current period is CNY -5,426,876.19, compared to CNY -30,441,238.79 in the previous period[41] - The company reported a significant increase in investment income of 2,145.16% to ¥6,826,084.05 from ¥304,036.20 due to gains from the disposal of subsidiary equity[16] - The company reported an investment income of CNY 6,826,084.05 for the current period, with no investment income reported in the previous period[39] Assets and Liabilities - Total assets decreased by 28.26% to ¥880,016,385.41 compared to the end of the previous year[9] - Current liabilities increased from CNY 400,321,585.69 to CNY 769,696,632.97, an increase of approximately 92.2%[31] - Total liabilities rose from CNY 414,445,456.83 to CNY 783,820,020.34, marking an increase of around 89%[31] - Owner's equity decreased from CNY 465,571,412.35 to CNY 442,872,397.02, a decline of about 4.9%[32] - The company has an accumulated deficit of CNY -1,493,317,330.47 in retained earnings[64] Cash Flow - Net cash flow from operating activities decreased by 68.50% to ¥54,803,106.71 year-to-date[9] - Cash received from the sale of goods and services dropped by 77.42% to ¥108,777,383.74 from ¥481,701,890.57, attributed to reduced sales volume[17] - Cash paid for purchasing goods and services decreased by 97.31% to ¥6,885,529.16 from ¥255,705,730.11, reflecting a reduction in procurement volume[17] - The cash inflow from operating activities for Q3 2019 was CNY 135,028,231.07, a decrease from CNY 536,427,055.17 in the previous year[53] - The net cash flow from operating activities for Q3 2019 was CNY 54,803,106.71, a decrease from CNY 173,961,072.91 in the previous period[54] - The company reported a net increase in cash and cash equivalents of CNY 3,059,277.51, contrasting with a decrease of CNY 88,794,846.77 in the previous period[55] Shareholder Information - The company had a total of 39,500 shareholders at the end of the reporting period[11] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management, held 15.46% of shares[11] - No share repurchase transactions were conducted by the top 10 shareholders during the reporting period[13] Inventory and Receivables - Accounts receivable increased significantly by 464.68% to ¥53,050,579.00 from ¥9,394,830.00 as a result of sales of products[16] - Inventory decreased by 73.08% to ¥65,291,855.94 from ¥242,546,184.67 due to product sales[16] Compliance and Audit - There were no violations regarding external guarantees during the reporting period[24] - The company has not undergone an audit for the third quarter report[68] - The company has not disclosed any new product developments or market expansion strategies in this report[68]
中基健康(000972) - 2019 Q3 - 季度财报
2019-10-30 16:00
Financial Performance - Operating revenue fell by 99.21% to ¥799,854.20, with a year-to-date revenue decline of 54.07% to ¥201,077,915.27[10] - Net profit attributable to shareholders was a loss of ¥5,350,650.69, with a year-to-date net profit of ¥22,860,511.96[10] - Basic and diluted earnings per share were both -¥0.007, reflecting an increase of 83.93% compared to the same period last year[10] - Total operating revenue for the current period is CNY 799,854.20, a significant decrease from CNY 101,822,430.00 in the previous period[38] - The net profit for the current period is a loss of CNY 5,426,876.19, compared to a loss of CNY 32,642,270.56 in the previous period, indicating an improvement[40] - The total comprehensive income for the current period is CNY -5,426,876.19, compared to CNY -30,441,238.79 in the previous period[41] - The company reported an operating profit of CNY -6,157,577.56 for the current period, an improvement from CNY -31,859,402.95 in the previous period[40] Cash Flow and Liquidity - Net cash flow from operating activities decreased by 68.50% to ¥57,103,106.71 year-to-date[10] - Cash received from sales of goods and services dropped by 77.42% to ¥108,777,383.74 from ¥481,701,890.57, indicating a decrease in sales volume[17] - The company reported a net cash inflow from the recovery of investments amounting to ¥24,779,960.00, marking a 100% increase from zero[17] - The cash inflow from operating activities for Q3 2019 was CNY 135,028,231.07, down from CNY 536,427,055.17 in the same period last year[53] - The company reported a cash flow net increase of CNY 3,059,277.51, contrasting with a decrease of CNY 88,794,846.77 in the previous period[55] Assets and Liabilities - Total assets decreased by 28.26% to ¥880,016,385.41 compared to the end of the previous year[10] - Current liabilities increased from CNY 400,321,585.69 to CNY 769,696,632.97, an increase of approximately 92.2%[31] - Total liabilities rose from CNY 414,445,456.83 to CNY 783,820,020.34, marking an increase of around 89%[31] - Non-current assets decreased from CNY 607,680,566.17 to CNY 435,503,293.97, representing a reduction of about 28.3%[30] - The company's total liabilities were CNY 783,820,020.34, while total equity stood at CNY 442,872,397.02[64] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 39,500[12] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 15.46% of shares[12] - The company does not have any preferred shareholders[14] - There were no repurchase transactions conducted by the top 10 shareholders during the reporting period[13] Inventory and Receivables - Accounts receivable increased significantly by 464.68% to ¥53,050,579.00 from ¥9,394,830.00 due to sales[16] - Inventory decreased by 73.08% to ¥65,291,855.94 from ¥242,546,184.67, reflecting product sales[16] - The company has a significant amount of other receivables totaling CNY 627,703,543.77, indicating potential liquidity issues[65] Investment and Income - Investment income surged by 2,145.16% to ¥6,826,084.05 from ¥304,036.20, resulting from gains from the disposal of subsidiary equity[16] - The company recorded investment income of CNY 6,826,084.05 in the current period, with no investment income reported in the previous period[38] Tax and Expenses - The company experienced a 99.60% decline in tax refunds received, totaling ¥107,696.61 compared to ¥26,640,018.37 in the previous year[17] - The company incurred tax expenses of CNY 219,960.76 in the current period, a decrease from CNY 1,328,624.62 in the previous period[38] - The company has reported a decrease in management expenses to CNY 10,614,383.90 from CNY 13,261,633.81 in the previous period[38] General Observations - The company has not reported any significant new strategies, product developments, or market expansions during the reporting period[18] - The report indicates that the third-quarter results have not been audited[68] - The company is in compliance with the new financial instrument standards and lease standards effective from 2019[68]
中基健康(000972) - 2019 Q2 - 季度财报
2019-08-29 16:00
Financial Performance - The company's operating revenue for the first half of 2019 was ¥200,278,061.07, a decrease of 40.40% compared to ¥336,010,975.33 in the same period last year[19]. - The net profit attributable to shareholders was ¥28,211,162.65, a significant improvement from a loss of ¥83,846,141.90 in the previous year[19]. - The basic earnings per share increased to ¥0.0366 from a loss of ¥0.1087 in the same period last year[19]. - The company achieved total operating revenue of ¥200,278,061.07, a decrease of 40.40% compared to the same period last year, primarily due to a reduction in sales volume of large-pack tomato sauce[31]. - The net profit attributable to the parent company was ¥28,211,162.65, with net assets attributable to shareholders amounting to ¥466,699,773.21[31]. - The company reported a significant reduction in sales expenses by 99.32% to ¥193,963.95, attributed to decreased delivery costs[33]. - The company reported a net profit of approximately 37.43 million, with a total revenue of about 195.36 million during the reporting period[47]. - The company reported a net loss of CNY 1,465,106,167.82, compared to a loss of CNY 1,493,317,330.47 in the previous period, indicating a slight improvement[134]. - The company reported a decrease in comprehensive income compared to the previous period, highlighting potential operational issues[161]. Cash Flow and Assets - The net cash flow from operating activities was ¥33,811,759.18, down 50.09% from ¥67,745,581.37 year-on-year[19]. - The company’s cash and cash equivalents increased by ¥7,196,289.76, contrasting with a decrease of ¥60,090,593.07 in the previous year[33]. - The company’s cash and cash equivalents decreased from 56,563,185.72 RMB at the end of 2018 to 40,678,330.06 RMB by June 30, 2019, a decline of approximately 28.14%[131]. - The total cash and cash equivalents at the end of the period were CNY 39,992,727.03, compared to CNY 63,658,051.30 at the end of the first half of 2018[148]. - The total assets at the end of the reporting period were ¥1,056,412,838.36, a decrease of 13.88% from ¥1,226,692,417.36 at the end of the previous year[19]. - The total current assets slightly increased from CNY 676,042,336.43 to CNY 677,832,025.34, a marginal increase of about 0.3%[137]. - The company’s fixed assets decreased from CNY 495,465,913.18 to CNY 427,117,772.82, a decline of approximately 13.8%[132]. Expenses and Liabilities - Operating costs decreased by 43.83% to ¥188,703,101.41, reflecting the same decline in sales volume of large-pack tomato sauce[33]. - Financial expenses were reduced by 59.64% to ¥7,978,665.00, resulting from decreased borrowings and interest expenses[33]. - The company's total liabilities decreased from CNY 783,820,020.34 to CNY 585,414,549.82, representing a reduction of approximately 25.3%[134]. - Current liabilities increased from CNY 769,696,632.97 to CNY 571,291,162.45, a decrease of about 25.8%[133]. Strategic Initiatives - The company has been actively pursuing asset restructuring and optimization to improve asset quality and enhance sustainable development capabilities[31]. - The company is in the process of transferring 100% equity of Tianjin Zhongchen Canned Food Co., Ltd., aiming to reduce financial burdens and promote business transformation[45]. - The company plans to utilize capital market financing and restructuring effects to enhance its risk resistance and achieve diversified operations[51]. - The company plans to continue focusing on market expansion and new product development to drive future growth[142]. Legal Matters - The company is involved in a significant legal dispute with MasterCard regarding a leasing contract, with claims for management fees totaling CNY 9,994,740.00 and inventory losses of CNY 18,100,667.52[60]. - The Tianjin Intermediate People's Court ruled in favor of the company, ordering MasterCard to pay the claimed management fees and inventory losses, but MasterCard has appealed the decision[65]. - Red Tomato requested compensation of CNY 12,398,555.95 for economic losses due to non-compliance with shipping instructions from Tianjin Coal Trading Company[71]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 40,412[116]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., held 15.46% of shares, totaling 119,243,804 shares[117]. - The second-largest shareholder, Xinjiang Guoheng Investment Development Group Co., held 12.97% of shares, totaling 100,000,000 shares[117]. Environmental and Regulatory Compliance - The company is classified as a key pollutant discharge unit and has implemented a wastewater treatment facility with a processing capacity of 450 m³/H[103]. - The company has established an emergency response plan for environmental incidents and has complied with environmental regulations[103]. Miscellaneous - The half-year financial report has not been audited[58]. - The company did not distribute cash dividends or bonus shares for the half-year period[55]. - There were no stock incentive plans or employee stock ownership plans implemented during the reporting period[88]. - The company has not engaged in any poverty alleviation work during the reporting period and has no future plans for such initiatives[105].
ST中基:关于参加2019年新疆辖区上市公司投资者网上集体接待日活动的公告
2019-07-19 08:40
Group 1: Event Details - The company will participate in the 2019 Xinjiang Listed Companies Investor Online Reception Day on July 26, 2019, from 15:00 to 17:30 [1] - The event will be held online via the platform provided by Shenzhen Panorama Network Co., Ltd. [1] - Investors can access the event through the "Panorama Roadshow World" website or the WeChat public account "Panorama Finance" [1] Group 2: Attendees - The attendees include Chairman Mr. Li Yu, CFO Ms. Luo Qiong, and Secretary of the Board Mr. Xing Jiang [1] Group 3: Company Assurance - The company and its board members guarantee the authenticity, accuracy, and completeness of the announcement, with no false records or misleading statements [1]
中基健康(000972) - 2019 Q1 - 季度财报
2019-04-29 16:00
Revenue and Profitability - The company's revenue for Q1 2019 was ¥91,484,302.22, representing a 93.30% increase compared to ¥47,328,180.62 in the same period last year[8] - The net profit attributable to shareholders was -¥8,966,936.17, a decrease of 10.16% from -¥9,981,246.45 year-on-year[8] - Revenue increased by 93.30% to ¥91,484,302.22 driven by higher sales volume of bulk tomato sauce[15] - Operating profit for Q1 2019 was a loss of CNY 9,175,350.13, compared to a loss of CNY 11,277,169.72 in the previous year, showing an improvement of 18.6%[34] - The net profit for the first quarter was -9,035,125.01, an improvement from -10,923,594.92 in the previous period, showing a reduction in losses[36] - The total comprehensive income for the first quarter was -9,035,125.01, compared to -11,816,701.26 in the previous period, showing an improvement[36] Cash Flow and Liquidity - The net cash flow from operating activities was -¥13,002,306.18, compared to ¥6,407,367.83 in the previous year, indicating a significant decline[8] - Cash received from sales dropped by 85.58% to ¥21,623,066.04, primarily due to reliance on accounts receivable[15] - The company received cash from operating activities totaling 23,488,846.89, down from 197,344,569.85 in the previous period[43] - The net cash flow from financing activities was -16,172,991.27 CNY, resulting in a total cash and cash equivalents balance of 39,973,833.69 CNY at the end of the period[44] - The net cash flow from investment activities was 12,585,950.69 CNY, primarily from cash received for investment recovery[47] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,142,589,492.98, down 6.86% from ¥1,226,692,417.36 at the end of the previous year[8] - The total assets decreased from ¥1,226,692,417.36 to ¥1,142,589,492.98, reflecting a decline in both current and non-current assets[27] - Total liabilities decreased to CNY 55,333,694.43 from CNY 48,749,467.05, reflecting an increase of 13.1%[33] - The company reported a total equity attributable to shareholders of 438,488,610.56 CNY, with a negative retained earnings of -1,493,317,330.47 CNY[51] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 42,033[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of the shares[10] Inventory and Operating Costs - Operating costs surged by 165.80% to ¥87,733,345.57, also attributed to increased sales volume of bulk tomato sauce[15] - Inventory decreased by 34.71% to ¥158,354,275.81 due to product sales[15] - The company’s inventory stood at 242,546,184.67 CNY, indicating a significant asset allocation towards stock[50] Financial Ratios and Performance Metrics - The basic earnings per share were -¥0.0116, an improvement of 10.08% compared to -¥0.0129 in the same period last year[8] - The weighted average return on net assets was -2.20%, a decrease of 0.96 percentage points from -1.24% year-on-year[8] - The company reported operating expenses of 3,238,859.19, down from 3,567,405.54 in the previous period, reflecting cost control efforts[38] Other Financial Information - The company reported no non-recurring gains or losses during the reporting period[8] - The company reported an undistributed profit of -1,233,900,002.58, indicating a significant loss[54] - The first quarter report was not audited, which may affect the reliability of the financial data presented[56] - The company adopted new financial instrument standards effective January 1, 2019, without retrospective adjustments affecting prior years[55]
中基健康(000972) - 2018 Q4 - 年度财报
2019-04-29 16:00
Financial Performance - The company's operating revenue for 2018 was ¥626,669,589.53, representing a 21.05% increase compared to ¥517,710,604.78 in 2017[17] - The net profit attributable to shareholders was -¥423,854,369.08, a significant decline from a profit of ¥36,689,853.12 in the previous year[17] - The net cash flow from operating activities improved to ¥416,334,994.00, compared to -¥176,181,920.66 in 2017[17] - Total assets at the end of 2018 were ¥1,226,692,417.36, a decrease of 47.74% from ¥2,445,329,852.45 in 2017[18] - The net assets attributable to shareholders decreased by 50.06% to ¥438,488,610.56 from ¥882,362,014.79 in 2017[18] - The basic earnings per share for 2018 was -¥0.55, down from ¥0.05 in 2017[17] - The weighted average return on equity was -64.39%, a decline of 67.49 percentage points from 4.28% in the previous year[17] - The company reported a net profit attributable to shareholders of -¥430,466,467.26, indicating ongoing financial challenges[36] Revenue Breakdown - The manufacturing sector contributed ¥613,359,200.82, accounting for 97.88% of total revenue, with a year-on-year growth of 22.79%[41] - The large bucket tomato sauce sales reached ¥519,702,876.01, which is 82.93% of total revenue, showing a significant increase of 77.49% compared to the previous year[41] - Domestic sales surged to ¥546,859,634.70, a remarkable increase of 141.56% from ¥226,383,514.18, while international sales plummeted by 72.60% to ¥79,809,954.83[41] - The total revenue for 2018 was 630,820,848.05 CNY, a decrease of 21.38% compared to 2017[44] - Domestic sales accounted for 533,549,245.99 CNY, down 15.52% year-over-year, while international sales dropped by 37.96% to 79,809,954.83 CNY[44] Operational Challenges - The company has faced significant financial challenges, as indicated by the substantial losses reported in the net profit figures[17] - The gross profit margin for the manufacturing sector fell to -18.44%, reflecting a significant decline in profitability[43] - The company is facing high production costs and insufficient operational funds, leading to significant financial pressure[38] - The company decided to halt production at certain subsidiaries to mitigate losses due to reduced tomato supply and rising costs, providing a necessary opportunity for reform[37] Strategic Plans and Investments - The company plans to enhance its market competitiveness by optimizing resource allocation and improving asset quality, including the shutdown of certain subsidiaries[27] - The company has invested in mechanized harvesting, which can reduce labor costs by 40%-60%, thereby improving efficiency and quality in tomato production[31] - The company aims to combine asset management with capital operations to ensure sustainable and stable development[27] - The company is focusing on developing high-value-added products such as tomato health cosmetics and beverages to enhance profitability[74] - The company is exploring mergers and acquisitions to expand its business scope in the health industry and increase profit growth points[74] Legal Matters - The company has filed a lawsuit against Tianjin Master Printing and Iron Packaging Co., Ltd. for a lease contract dispute, claiming a total compensation of 67,877,894.95 yuan, which includes management fees, advances, and guarantee deposits[99] - The company has been involved in multiple legal disputes, including a case against its subsidiary Tianjin Zhongchen Canned Co., Ltd. for a total debt of 27,286,749.53 yuan[102] - The ongoing legal disputes highlight the complexities and risks associated with logistics and supply chain contracts in the industry[110] Environmental and Social Responsibility - The company has established an emergency response plan for environmental incidents, in accordance with the Environmental Protection Law of the People's Republic of China[145] - The company has created over 4,000 long-term fixed job opportunities and provided 8,000 seasonal job opportunities annually in Xinjiang[137] - The company is recognized as a key agricultural industrialization leading enterprise and has contributed significantly to the economic development of Xinjiang[136] Governance and Management - The company is focused on maintaining a strong governance structure with independent directors and supervisors to ensure compliance and accountability[166] - The management team includes experienced professionals with extensive backgrounds in investment and project management, which is crucial for the company's growth strategy[171] - The company has established a performance evaluation and incentive mechanism based on a fair and transparent salary system[185] Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion RMB[178] - New product launches are expected to contribute an additional 200 million RMB in revenue, with a focus on health supplements and organic products[178] - The company aims to improve operational efficiency, targeting a reduction in production costs by 8% through process optimization[178]